Compare NAKA & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NAKA | OPRX |
|---|---|---|
| Founded | 2019 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Business Services |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 152.1M | 137.3M |
| IPO Year | 2023 | 2008 |
| Metric | NAKA | OPRX |
|---|---|---|
| Price | $9.97 | $8.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | $0.75 | ★ $16.67 |
| AVG Volume (30 Days) | ★ 207.4K | 130.8K |
| Earning Date | 05-20-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 61.19 | ★ 124.55 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $109,429,000.00 |
| Revenue This Year | $1,514.38 | $3.88 |
| Revenue Next Year | $48.27 | $8.34 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 18.78 |
| 52 Week Low | $0.15 | $4.54 |
| 52 Week High | $10.27 | $22.25 |
| Indicator | NAKA | OPRX |
|---|---|---|
| Relative Strength Index (RSI) | 70.27 | 58.78 |
| Support Level | $0.24 | $7.80 |
| Resistance Level | N/A | $8.30 |
| Average True Range (ATR) | 0.60 | 0.38 |
| MACD | 0.08 | 0.01 |
| Stochastic Oscillator | 90.41 | 65.32 |
Nakamoto Inc is a Bitcoin company building a world-wide portfolio of Bitcoin-native companies to provide commercial and financial infrastructure for the next generation of capital markets. The firm has two principal business segments: Bitcoin Operations, which houses its Bitcoin treasury and is utilized to support investments in other Bitcoin-related companies; Healthcare Operations, which provides a patient-focused healthcare experience that provides patients personalized solutions in order to reduce opioid use and improve health outcomes. The company generates the majority of its revenue from the Healthcare Operations.
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.